Melatonin as a sedation substitute for diagnostic procedures

Developmental Medicine and Child Neurology

Volumn 42, Issue 9, 2000, Pages 646-647

  Espezel, H ^a   Graves, C ^a   Jan, J E ^a   Miller, A ^a   Renner, K ^a   Gustin, C ^a   Dominelli, E ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAL HYDRATE; MELATONIN;

AUDITORY THRESHOLD; BRAIN ARACHNOID CYST; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DYSTONIA; EPILEPSY; HEARING LOSS; HUMAN; LETTER; PRIORITY JOURNAL; SEDATION; SENSORY DYSFUNCTION; SLEEP; SLEEP DISORDER;

EID: 0033834566     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0012162200221191     Document Type: Letter

References (6)

1. Sleep promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanism
2. Daytime melatonin administration enchances sleepiness and theta/alpha activity in the waking EEG
3. Melatonin treatment of sleep-wake cycle disorders in children and adolescents
4. Melatonin for sleep EEG
5. Premedication with melatonin: A double-blind, placebo-controlled comparison with midazolam
6. Melatonin effect on daytime sleep in men: Suppression of EEG low frequency activity and enhancement of spindle frequency activity